| Literature DB >> 34368374 |
Seong Hwan Kim1,2, Yong-Beom Park2, Boo-Seop Kim3, Dong-Hoon Lee3, Nicolas Pujol1.
Abstract
BACKGROUND: The incidence of concomitant injuries, including meniscal and cartilage injuries, has not been adequately reported in previous studies on multiligament knee injury (MLKI) because their primary focal points have been the degree of ligament injury, treatment strategy, involvement of other soft tissues, and neurovascular injury.Entities:
Keywords: anterior cruciate ligament; cartilage; meniscus; meta-analysis; multiligament knee injury; outcomes
Year: 2021 PMID: 34368374 PMCID: PMC8312178 DOI: 10.1177/23259671211010409
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Figure 1.Flow diagram of the article selection process using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. MLKI, multiligament knee injury.
Results From Studies on Multiligament Knee Injury
| Combined Injuries, No. (%) | Mean ± SD (Range) | ||||||
|---|---|---|---|---|---|---|---|
| Lead Author (Year) | No. of Patients | Ligament | Meniscal | Cartilage | No. of Complications | Time From Trauma to Surgery | Follow-up |
| Krych (2015)
| 122 | Multiligament | MM tear: 40 | 52 | 62 early (<3 mo) | ||
| Lind (2009)
| 457 | Multiligament | 73 (16) | 21.9% early (<0.5 y)53.4% delayed (0.5-5 y)24.7% chronic (>5 y) | 2 y after surgery | ||
| King (2015)
| 95 | Multiligament (knees with only ACL-MCL or ACL-PLC injuries excluded) | MM tear: 32 | 38 | Mean 8 mo | 6 y (2-20 y) | |
| King (2016)
| 56 | Multiligament (ACL-PCL-MCL and ACL-PCL-LCL) | Peroneal nerve injury: 12 | ACL-PCL-MCL: 9.8 ± 23.3 mo | ACL-PCL-MCL: 78.3 ± 60.4 mo | ||
| Tardy (2017)
| 39 | Multiligament, PMC vs PLC, combined ACL or PCL injury | MM tear: 11 | Arthrofibrosis: 5 | 28 acute (<3 wk)11 chronic (>3 wk) | Median, 57 mo (12-129 mo) | |
| Alentorn-Geli (2019)
| 39 | Multiligament | MM tear: 17 | 17 | Peroneal nerve injury: 2 | 36 acute (8 ± 5.3 wk) | Median, 27 mo (12-84 mo) |
| Levy (2015)
| 125 | Multiligament | Total: 73 | 50 | Peroneal nerve injury: 28 | Median, 5 y (2-22 y) | |
| Derby (2017)
| 38 | Multiligament | MM tear: 14 | 26 acute (<3 mo) | |||
| Moatshe (2017)
| 65 | ACL-PCL rupture with/without collateral ligament injury | Total: 25 | 25 | Peroneal nerve injury: 15 | 33 acute (<21 d) | 13.1 y (10-18.8 y) |
| Lind (2018)
| 344 | Multiligament injury | Total: 79 (23) | 55 (16) | 5.7 ± 2.9 y | ||
| Woodmass (2018)
| 62 | Multiligament injury including fracture | Peroneal nerve injury: 7 | 10 acute (<3 wk) | 67 mo (24-220 mo) | ||
| Hongwu (2018)
| 13 | Multiligament injury | Arthrofibrosis: 1 | 1.84 d (1-3 d) | 32.6 mo (24-46 mo) | ||
| Chahla (2017)
| 105 | Multiligament injury | MM tear: 26 | 24 | Arthrofibrosis: 5 | 72 acute (<6 wk) | 3.0 y (2.0-4.7 y) |
| Yeh (1999)
| 25 | Multiligament injury | MM tear: 16 | 3 | Peroneal nerve injury: 2 | 11.1 ± 5 d (5-25 d) | 27.2 ± 7.86 mo |
| Levy (2010)
| 9 | Multiligament injury | Arthrofibrosis: 1 | 75 d (21-171 d) | 4 mo (13-32 mo) | ||
| Liow (2003)
| 22 | Multiligament injury including fracture | Peroneal nerve injury: 1 | 8 acute (<2 wk) | 32 mo (11-77 mo) | ||
| Sanders (2017)
| 48 | Multiligament injury including fracture | Total: 30 | 17 | Peroneal nerve injury: 30 | 13 acute (<3 wk) | 8.3 ± 5.0 y (2.1-21.8 y) |
| Subbiah (2011)
| 19 | Multiligament injury | MM tear: 11 | 11 acute (<3 wk) | 22 mo (14-33 mo) | ||
| Tao (2013)
| 9 | Multiligament injury | MM tear: 4 | Acute (<3 wk): 11.4 ± 4.8 d | 30 mo (18-46 mo) | ||
| Zhang (2013)
| 59 | Multiligament injury including fractures | Arthrofibrosis: 2 | 48 acute (<3 wk): 7.3 d (1-13 d) | 2.5 y (1.75-3.75 y) | ||
| Kosy (2018)
| 226 | Multiligament injury including fractures | MM root tear: 20 | All within 2 wk of trauma | |||
| Khakha (2016)
| 36 | Multiligament injury | Peroneal nerve injury: 8 | All within 3 wk after trauma | 10.1 y (7-19 y) | ||
| Richter (2002)
| 68 | Multiligament | MM tear: 28 | Peroneal nerve injury: 5 | 10.6 ± 26.6 d (0-140 d) | 8.2 y (2-25 y) | |
| Tzurbakis (2006)
| 48 | ACL + medial side: 12 (25) | MM tear: 20 | 6 | Arthrofibrosis: 5 | 38 acute (<3 wk): 7.47 ± 5.82 d | 51.3 ± 28.9 mo (24-96 mo) |
| Noyes (1997)
| 11 | Multiligament including fracture | Total: 5 | 3 | Arthrofibrosis: 6 | 7 acute (<2 wk) | 4.5 y (2.5-6.9 y) |
| Harner (2004)
| 47 | Multiligament | Peroneal nerve injury: 4 | 19 acute (<3 wk) | 44 mo (2-6 y) | ||
| Owens (2007)
| 28 | Multiligament | Total: 14 | Peroneal nerve injury: 4 | All within 2 wk of trauma (17 d [1-101 d]) | 48 mo (13-82 mo) | |
| Engebretsen (2009)
| 85 | Multiligament including fracture | MM tear: 17 | 22 | Peroneal nerve injury: 18 | 50 acute (<2 wk) | 5.3 ± 1.9 y |
| Jenkins (2011)
| 20 | ACL-MCL: 1 (5); ACL-PCL: 3 (15); ACL-PLC: 4 (20); PCL-PLC: 2 (10); ACL-PCL-PLC: 8 (40); ACL-MCL-PCL: 2 (10) | MM tear: 2 | 1 | Peroneal nerve injury: 3 | 6 acute (<3 wk): 3.3 d (1-7 d) | 2 y |
| Werner (2014)
| 65 | KD 3 M: 32 (49.2); KD 4: 33 (50.8) | MM tear: 14 | Peroneal nerve injury: 6 | All within 3 wk | 6.2 y (1.1-11.6 y) | |
| Talbot (2004)
| 21 | KD 2: 1 (4.8); KD 3 M: 9 (42.9); KD 3 L: 10 (47.6); KD 4: 1 (4.8) | MM tear: 11 | Peroneal nerve injury: 8 | All within 3 wk | 27.4 mo | |
| Eranki (2010)
| 20 | Multiligament including fracture (ACL-PCL-MCL most common, PCL-LCL-PLC second, ACL-PCL-MCL-LCL-PLC third) | Peroneal nerve injury: 6 | All within 14 d | 24 mo | ||
| Hua (2016)
| 18 | Multiligament including fracture | Peroneal nerve injury: 13 | All within 2 wk (5-10 d after injury) | 4.8 ± 1.3 y | ||
| Almekinders (1992)
| 31 | Multiligament | Peroneal nerve injury: 5 | 40 mo | |||
| Roman (1987)
| 30 | Multiligament | Peroneal nerve injury: 4 | ||||
| Wascher (1999)
| 13 | ACL-PCL-MCL: 7 (53.8); ACL-PCL-PLC: 6 (46.2) | MM tear: 4 | Peroneal nerve injury: 2 | 9 acute (<3 wk) | 38.4 mo | |
| Fanelli (1996)
| 21 | All were PCL-PLC injuries | Arthrofibrosis: 1 | 10 acute | 24 mo (24-54 mo) | ||
| Frassica (1991)
| 20 | Multiligament including fracture | Vascular injury: 17 | 12 within 5 d | 57 mo (22-96 mo) | ||
| Hirschmann (2010)
| 24 | KD 3 M: 12 (50); KD 3 L: 8 (33); KD 4: 4 (17) | MM tear: 4 | Peroneal nerve injury: 1 | 12 within 1 wk | 8 y (1-23 y) | |
| Ibrahim (2008)
| 36 | ACL-PCL-MCL: 15 (75); ACL-PCL-PLC: 5 (25); others excluded | Vascular injury: 5 | 2-3 wk after injury | 43 mo | ||
| Wajsfisz (2014)
| 53 | Multiligament | MM tear: 3 | Peroneal nerve injury: 1 | 10 early (<3 wk) | 49 mo (12-146 mo) | |
| Wyatt (2017)
| 549 | Multiligament | MM tear: 167 | 174 | |||
| Lustig (2009)
| 67 | Multiligament | 16 | Peroneal nerve injury: 12 | |||
| Twaddle (2003)
| 63 | Multiligament | Peroneal nerve injury: 12 | ||||
| Freychet (2020)
| 40 | Multiligament | Total: 22 | 13 | Peroneal nerve injury: 18 | 20 single-stage surgery | ≥2 y |
Blank cells indicate not reported. ACL, anterior cruciate ligament; KD, knee dislocation classification; L, lateral; LCL, lateral collateral ligament; LM, lateral meniscus; M, medial; MCL, medial collateral ligament; MM, medial meniscus; PCL, posterior cruciate ligament; PLC, posterolateral corner; PMC, posteromedial corner.
Included in clinical analysis: n = 31.
Confirmed using arthroscopy.
Quality Assessment of the Included Studies
| Internal Validity | ||||||||
|---|---|---|---|---|---|---|---|---|
| Lead Author (Year) | Study Design (Level of Evidence) | No. of Patients | Reporting | External Validity | Bias | Confounding (Selection Bias) | Power | Total |
| Krych (2015)
| Retrospective (3) | 122 | 3 | 1 | 3 | 3 | 5 | 15 |
| King (2015)
| Retrospective (3) | 95 | 5 | 1 | 3 | 3 | 4 | 16 |
| King (2016)
| Retrospective comparative (3) | 56 | 5 | 1 | 2 | 2 | 3 | 13 |
| Tardy (2017)
| Retrospective (3) | 39 | 4 | 1 | 3 | 3 | 2 | 13 |
| Alentorn-Geli (2019)
| Retrospective cross-sectional comparative (3) | 39 | 5 | 1 | 3 | 3 | 2 | 14 |
| Levy (2015)
| Retrospective (3) | 125 | 4 | 1 | 3 | 3 | 5 | 16 |
| Derby (2017)
| Retrospective diagnostic (2) | 38 | 6 | 1 | 3 | 2 | 2 | 14 |
| Moatshe (2017)
| Retrospective cohort (3) | 65 | 9 | 1 | 4 | 3 | 4 | 21 |
| Hongwu (2018)
| Retrospective cohort (4) | 13 | 4 | 1 | 3 | 3 | 0 | 11 |
| Woodmass (2018)
| Retrospective cohort (3) | 62 | 9 | 1 | 3 | 3 | 4 | 20 |
| Chahla (2017)
| Retrospective cohort (3) | 105 | 9 | 1 | 5 | 3 | 5 | 23 |
| Yeh (1999)
| Retrospective cohort (4) | 25 | 4 | 1 | 3 | 3 | 1 | 12 |
| Levy (2010)
| Retrospective cohort (4) | 9 | 5 | 1 | 3 | 3 | 0 | 12 |
| Liow (2003)
| Retrospective cohort (4) | 22 | 5 | 1 | 3 | 3 | 1 | 13 |
| Subbiah (2011)
| Retrospective cohort (4) | 19 | 7 | 1 | 3 | 2 | 0 | 13 |
| Tao (2013)
| Retrospective cohort (4) | 9 | 8 | 1 | 3 | 2 | 0 | 14 |
| Zhang (2013)
| Retrospective cohort (3) | 59 | 7 | 1 | 3 | 2 | 3 | 16 |
| Sanders (2017)
| Retrospective cohort (3) | 48 | 7 | 1 | 4 | 2 | 3 | 17 |
| Richter (2002)
| Retrospective case-control (3) | 68 | 5 | 1 | 3 | 3 | 4 | 16 |
| Kosy (2018)
| Retrospective cohort (3) | 226 | 5 | 1 | 2 | 0 | 5 | 13 |
| Khakha (2016)
| Prospective cohort (2b) | 36 | 6 | 1 | 3 | 2 | 2 | 14 |
| Tzurbakis (2006)
| Retrospective cohort (3) | 48 | 5 | 1 | 2 | 0 | 3 | 11 |
| Noyes (1997)
| Retrospective cohort (4) | 11 | 3 | 1 | 2 | 0 | 0 | 6 |
| Harner (2004)
| Retrospective cohort (3) | 47 | 9 | 1 | 3 | 3 | 2 | 18 |
| Owens (2007)
| Retrospective cohort (4) | 28 | 4 | 1 | 2 | 0 | 1 | 8 |
| Engebretsen (2009)
| Prospective cohort (2) | 85 | 8 | 1 | 3 | 2 | 4 | 18 |
| Jenkins (2011)
| Retrospective cohort (4) | 20 | 6 | 1 | 3 | 0 | 1 | 10 |
| Werner (2014)
| Retrospective cohort (3) | 65 | 4 | 1 | 3 | 2 | 4 | 14 |
| Talbot (2004)
| Retrospective cohort (4) | 21 | 4 | 1 | 2 | 0 | 1 | 8 |
| Eranki (2010)
| Retrospective cohort (4) | 20 | 5 | 1 | 2 | 0 | 1 | 9 |
| Hua (2016)
| Retrospective cohort (4) | 18 | 6 | 0 | 2 | 0 | 0 | 8 |
| Almekinders (1992)
| Retrospective cohort (3) | 31 | 5 | 1 | 3 | 2 | 0 | 11 |
| Roman (1987)
| Retrospective cohort (3) | 30 | 2 | 1 | 2 | 0 | 2 | 7 |
| Wascher (1999)
| Retrospective cohort (4) | 13 | 5 | 1 | 2 | 0 | 0 | 8 |
| Fanelli (1996)
| Retrospective cohort (4) | 21 | 3 | 0 | 1 | 0 | 1 | 5 |
| Frassica (1991)
| Retrospective cohort (4) | 17 | 3 | 0 | 1 | 0 | 1 | 5 |
| Hirschmann (2010)
| Retrospective cohort (4) | 24 | 3 | 1 | 1 | 0 | 1 | 6 |
| Ibrahim (2008)
| Retrospective cohort (3) | 36 | 4 | 1 | 2 | 0 | 1 | 8 |
| Wajsfisz (2014)
| Retrospective cohort (3) | 53 | 6 | 1 | 3 | 2 | 3 | 15 |
| Lind (2018)
| Prospective cohort (registry data) (3) | 344 | 10 | 2 | 4 | 3 | 5 | 24 |
| Lind (2009)
| Prospective cohort (registry data) (3) | 457 | 10 | 2 | 4 | 3 | 5 | 24 |
| Wyatt (2017)
| Prospective cohort (2) | 549 | 10 | 2 | 4 | 3 | 5 | 24 |
| Lustig (2009)
| Prospective cohort (2) | 67 | 9 | 1 | 3 | 3 | 4 | 20 |
| Twaddle (2003)
| Prospective cohort (2) | 63 | 9 | 1 | 3 | 3 | 4 | 20 |
| Freychet (2020)
| Retrospective cohort (3) | 40 | 9 | 1 | 2 | 2 | 3 | 17 |
Figure A1.Funnel plots for publication bias in the studies on multiligament knee injury (MLKI). No evidence of asymmetry was found: (A) medial meniscal injury (P = .062), (B) lateral meniscal injury (P = .103), (C) cartilage injury (P = .198), (D) peroneal nerve injury in MLKI group (P = .371), (E) vascular injury in MLKI group (P = .069), and (F) arthrofibrosis (P = .073).
Figure 2.Proportional forest plot with 95% CIs for medial meniscal tears in multiligament knee injuries. The squares represent the results of each study. The ends of the horizontal bars represent 95% CIs. The diamond denotes the overall pooled proportion from all studies. The pooled proportion was 30.4% with substantial heterogeneity (95% CI, 24.1%-37.1%; P < .0001; I 2 = 85.8%).
Figure 3.Proportional forest plot with 95% CIs for lateral meniscal tears in multiligament knee injuries. The squares represent the results of each study. The diamond denotes the overall pooled proportion from all studies. The pooled proportion was 27.5% with substantial heterogeneity (95% CI, 20.3%-35.3%; P < .0001; I 2 = 89.6).
Figure 4.Proportional forest plot with 95% CIs for concomitant cartilage injury in multiligament knee injuries. The squares represent the results of each study. The diamond denotes the overall pooled proportion from all studies. The pooled proportion was 27.5% with substantial heterogeneity (95% CI, 22.1%-33.3%; P < .0001; I 2 = 86.8%).
Figure 5.Proportional forest plot with 95% CIs for peroneal nerve injury in multiligament knee injuries. The squares represent the results of each study. The diamond denotes the overall pooled proportion from all studies. The pooled proportion was 19.2% with substantial heterogeneity (95% CI, 14.2%-24.7%; P < .001; I 2 = 81.3%).
Figure 6.Proportional forest plot with 95% CIs for vascular injuries concomitant with multiligament knee injuries. The squares represent the results of each study. The diamond denotes the overall pooled proportion from all studies. The pooled proportion was 18.4% with substantial heterogeneity (95% CI, 13.2%-24.3%; P < .0001; I 2 = 81.0%).
Figure 7.Proportional forest plot with 95% CIs for arthrofibrosis in multiligament knee injuries. The squares represent the results of each study. The diamond denotes the overall pooled proportion from all studies. The pooled proportion was 11.2% with substantial heterogeneity (95% CI, 8.1%-14.7%; P = .0018; I 2 = 54.0%).